BeOne Medicines
ONC
#637
Rank
ยฃ27.50 B
Marketcap
ยฃ248.59
Share price
-1.91%
Change (1 day)
58.59%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

BeOne Medicines (ONC) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : ยฃ2.62 Billion

According to BeOne Medicines's latest financial reports the company's total liabilities are ยฃ2.62 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BeOne Medicines - Total liabilities on balance sheet (from 2014 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31ยฃ2.06 B15.88%
2023-12-31ยฃ1.78 B7.9%
2022-12-31ยฃ1.64 B-7.32%
2021-12-31ยฃ1.78 B40.14%
2020-12-31ยฃ1.27 B162.77%
2019-12-31ยฃ0.48 B23.71%
2018-12-31ยฃ0.39 B45.79%
2017-12-31ยฃ0.26 B525.12%
2016-12-31ยฃ42.87 M49.7%
2015-12-31ยฃ28.64 M60.1%
2014-12-31ยฃ17.88 M-41.59%
2013-12-31ยฃ30.62 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Onconova Therapeutics
ONTX
ยฃ9.11 M-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ0.51 B-80.30%๐Ÿ‡บ๐Ÿ‡ธ USA